Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Addiction

Ketone esters show promise as a new treatment for alcohol use disorder

by Vladimir Hedrih
April 14, 2026
in Addiction
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook

A small study comparing individuals with alcohol use disorder and healthy participants found that a single dose of a ketone ester supplement significantly reduced alcohol cravings in participants with alcohol use disorder and shifted brain energy use from glucose to ketones. The paper was published in Psychiatry Research: Neuroimaging.

Ketone esters are synthetic compounds designed to raise the level of ketone bodies in the blood without requiring fasting or a strict ketogenic diet. Ketones are alternative energy molecules produced naturally by the liver when carbohydrate intake is low, especially during fasting or prolonged exercise.

The rationale behind the study stems from how alcohol changes the brain’s metabolism. People who drink heavily adapt to using acetate (a byproduct of alcohol) for brain energy instead of glucose. When a person stops drinking, the sudden lack of acetate creates a brain energy deficit that is believed to trigger withdrawal symptoms and severe alcohol cravings. Researchers hypothesized that ketones, which act similarly to acetate, could serve as an alternative brain fuel to safely close this energy gap.

A ketone ester supplement typically contains molecules such as β-hydroxybutyrate (BHB) bound to an alcohol, which the body rapidly converts into usable ketones. These supplements can quickly induce a state of nutritional ketosis within minutes of ingestion.

Unlike ketone salts, ketone esters do not contain large amounts of minerals and therefore can deliver higher ketone levels more efficiently. They are sometimes used by athletes to (potentially) enhance endurance performance by providing an alternative fuel source. Some research suggests they may also affect cognitive function by supplying the brain with a steady energy substrate. However, the taste of ketone ester supplements is unpleasant (for most people), and they can cause gastrointestinal discomfort in some users.

Study author Xinyi Li and colleagues wanted to explore the effects of a single dose of a ketone ester supplement. They note that previous studies showed a single dose of ketone ester supplements to elevate BHB levels in blood 30 minutes after intake, with the effects peaking 45-60 minutes after intake. In this study, they investigated the effects on brain glucose metabolism in individuals with alcohol use disorder and healthy individuals. They also looked into how alcohol cravings changed after intake of this supplement.

Study participants included 5 individuals with alcohol use disorder and 5 healthy individuals. Participants were between 21 and 65 years of age; 3 of them were women and 7 were men. Healthy participants’ average age was 36 years, while the average age of individuals with alcohol use disorder was 31 years.

There were two treatment conditions – receiving no ketone ester supplement (baseline) and receiving 395 mg/kg of a ketone ester supplement. All participants went through both conditions in two visits to the laboratory, but the order in which they received the treatments was randomly determined for each participant. On each visit, they completed a PET scan.

Google News Preferences Add PsyPost to your preferred sources

The ketone ester supplement participants took was diluted with diet soda or sparkling water and given to participants 1 hour before they had a PET scan. The PET scan portion of the study was open-label, meaning no intervention was provided at the baseline visit and participants knew when they were receiving the supplement. Study participants gave blood samples at arrival to the laboratory, prior to injection of the radioactive glucose (that is needed for PET scans to work), 30 minutes later, and 60 minutes later.

Participants with alcohol use disorder also underwent magnetic resonance spectroscopy (MRS), allowing study authors to directly measure BHB levels inside the brain. Unlike the PET scans, this MRS portion of the study was double-blind and placebo-controlled; participants received either the ketone ester or a taste-matched, bitter dextrose placebo 45 minutes prior to the scan.

Results showed that the ketone ester supplement lowered blood glucose levels and increased BHB levels in both groups. Brain scans revealed a 17% reduction in glucose metabolism, especially in the frontal, occipital, and cingulate cortices of the brain, as well as in the hippocampus, amygdala, and insula regions.

The ketone ester supplement significantly reduced self-reported alcohol cravings in participants with alcohol use disorder. It also tripled BHB levels in the cingulate cortex region of their brains, proving the supplement successfully crossed the blood-brain barrier.

“These findings suggest that a single KE [ketone ester] dose can rapidly shift brain energy use from glucose to ketones, and may help reduce cravings in AUD [alcohol use disorder], supporting its potential as a therapeutic approach,” the study authors concluded.

The study contributes to the scientific understanding of the physiological and psychological effects of ketone ester supplements. However, it should be noted that the study was conducted on a very small group of participants. Because of this, effects needed to be of very substantial magnitude to be detectable.

The paper, “Pharmacokinetic effects of a single dose nutritional ketone ester supplement on brain glucose and ketone metabolism in alcohol use disorder,” was authored by Xinyi Li, Anthony J. Young, Zhenhao Shi, Juliana Byanyima, Sianneh Vesslee, Rishika Reddy, Timothy Pond, Mark Elliott, Ravinder Reddy, Robert K. Doot, Jan-Willem van der Veen, Henry R. Kranzler, Ravi Prakash Reddy Nanga, Jacob G. Dubroff, and Corinde E. Wiers.

Previous Post

Psychedelic therapy and traditional antidepressants show similar results under open-label conditions

RELATED

New study links honor cultures to higher rates of depression, suicidal thoughts
Addiction

Even mild opioid use disorder is linked to a significantly higher risk of suicide

April 13, 2026
Addiction

The unexpected link between loneliness, status, and shopping habits

April 10, 2026
Obesity before pregnancy linked to autism-like behavior in male offspring, study finds
Addiction

Early life stress fundamentally alters alcohol processing in the brain

April 7, 2026
New study claims antidepressant withdrawal is less common than thought. But there’s a big problem
Addiction

A common antidepressant shows promise in treating methamphetamine dependence

April 7, 2026
Neuroimaging study finds gray matter reductions in first-time fathers
Addiction

Brain scans reveal how poor sleep fuels negative emotions in alcohol addiction

March 28, 2026
Excessive smartphone habits tied to emotional dysregulation in the brain
Addiction

Excessive smartphone habits tied to emotional dysregulation in the brain

March 26, 2026
Loneliness predicts an increase in TV viewing for older women, but not for men
Addiction

Addiction is linked to inconsistent decision-making, not ignoring consequences

March 26, 2026
Does cannabidiol reduce worry severity or anxiety symptoms? New placebo-controlled study says no
Addiction

Cannabidiol may help treat severe alcohol addiction and protect the brain from damage

March 16, 2026

STAY CONNECTED

RSS Psychology of Selling

  • When happy customers and happy employees don’t add up: How investor signals have shifted in the social media age
  • Correcting fake news about brands does not backfire, five-study experiment finds
  • Should your marketing tell a story or state the facts? A massive meta-analysis has answers
  • When brands embrace diversity, some customers pull away — and new research explains why
  • Smaller influencers drive engagement while bigger ones drive purchases, meta-analysis finds

LATEST

Psychedelic therapy and traditional antidepressants show similar results under open-label conditions

Romances with narcissists don’t deteriorate the way psychologists expected

New research links personality traits to confidence in recognizing artificial intelligence deception

Trust and turbines: how conspiratorial thinking and wind farm opposition fuel each other

Advanced meditation techniques linked to younger brain age during sleep

Even mild opioid use disorder is linked to a significantly higher risk of suicide

120-year text analysis reveals how society’s view of lawyers’ personalities has shifted

Disrupted sleep is the primary pathway linking problematic social media use to reduced wellbeing

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc